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f d. Note - This overview was originally presented at the 
International Symposium on Clinical Disorders of Bone 
and Mineral Metabolism, May 9-13,1983. The following 
list indicates the presentations given in this session at the 
Symposium and the contents ofthe corresponding chap-
ter in the Proceedings of the Symposium published by 
Excerpta Medica. The numbers in parentheses refer to 
pages in this volume. Complete information about the 
contents of the Proceedings can be found at the back of 
this issue. 
Estimation of trabecular bone resorption by histomor-
phometry: Evidence for a prolonged reversal phase with 
normal resorption in post menopausal osteoporosis and 
coupled increased resorption in primary hyperparathy-
roidism. R. Baron, S. Magee, A. Silverglate, A. Broadhus, 
and R. Long (191) 
Mechanisms of parathyroid hormone mediated bone 
loss. L.G. Raisz (196) 
PTH mediated bone loss in primary and secondary 
hyperparathyroidism. M. Kleerekoper, A.R. Villanueva, 
C.H.E. Mathews, D.S. Rao, B. Pumo, and A .M. Parfitt (200) 
V/(am;n D deficiency and hip fractures: Cause or coinci-
dence? P. Lips, M.J.M. Jongen, F.C. van Giunkel, W.J.F. 
van der Vi jgh, R. Bouil lon, W.H.L. Hackeng, and J.C. 
Netelenbos (204) 
Osteoclastic resorption of osteoid in secondary hyper-
parathyroidism. Ming Cai Q iu , C. Mathews, and A .M. 
Parfitt (209) 
A m o n g the many causes of diminished skeletal mass, 
parathyroid hormone (PTH)-mediated bone resorption 
has been most widely studied experimentally, and age-
related osteoporosis is the least understood. Because of 
histologic heterogeneity, it has been assumed that the 
etiology of osteoporosis, either postmenopausal (Type I) 
or senile (Type II), is multifactoral (Riggs, et al, pp. 337 ff.). 
This session examined the possible contr ibution of PTH-
mediated bone loss to the pathogenesis of osteoporosis. 
Raisz (pp. 196 ff.) reviewed the actions of PTH on bone 
that might cause bone loss. Bone resorption is stimulated 
acutely, with an increase in both the activity and the 
number of osteoclasts. Since these cells lack PTH recep-
tors, the effect of the hormone may be mediated by 
action on the bone lining cells (Parfitt, et al, pp. 328 ff.). 
These and other cells of osteoblast lineage possess PTH 
receptors, and PTH acutely inhibits collagen synthesis. 
The longer term effect of increased bone formation is 
probably brought about by the coupling mechanism 
(Mohan, et al, pp. 173 ff.). Whether the summation of 
these short- and long-term effects is catabolic or anabolic 
may depend on the intake and absorption of dietary 
calcium and on the plasma phosphate level. 
Baron (pp. 191 ff.) reviewed the histologic assessment of 
bone resorption. Osteoclasts occupy only a small fraction 
of the total crenated (Howship's) lacunar surface. The 
remainder are covered by various kinds of mononuclear 
cells that appear in the t ime interval between the end of 
resorption and the beginning of formation and identify 
the so-called reversal surface. In hyperparathyroidism 
and other states of increased bone turnover, the increase 
in total resorption surface reflects an increase in osteo-
clast surface. On the other hand, in postmenopausal and 
other types of osteoporosis, the increase in total resorp-
tion surface reflects only an increase in reversal surface. 
Accordingly, increased total resorption surface is not a 
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valid index of increased resorption rate in osteoporosis. 
Qiu (pp. 209 ff.) reviewed another facet of the histologic 
assessment of bone resorption and found that osteoclasts 
normally avoid osteoid and resorb only unmineralized 
bone. However, osteoclastic resorption of osteoid may 
occur with the stimulus of severe hyperparathyroidism. 
Kleerekoper (pp. 200 ff.) demonstrated that chronic 
hyperparathyroidism, whether primary or secondary, 
accelerates age-related loss of cortical bone. Loss of tra-
becular bone, observed in only a small subset of patients 
with primary hyperparathyroidism, was more substantial 
in patients with secondary hyperparathyroidism due to 
gastrointestinal malabsorption of calcium. However, 
even in these patients, the relative deficit was signifi-
cantly greater for cortical than for trabecular bone. This 
conclusion differs f rom that o fother investigators, partly 
because of different interpretation of measurements by 
single photon absorpt iometry at the distal radius. 
Although this measurement is generally believed to 
indicate the loss of trabecular bone, our studies indicate 
that trabecular bone atthis site is metabolically inert and 
that, as at the proximal site, losses are due predominantly 
to cortical thinning. None of the studied patients had 
sustained a fracture, but in another session Rao demon-
strated a significant increase in fracture risk for patients 
with secondary hyperparathyroidism even without osteo-
malacia (Rao, et al, pp. 224 ff.). 
Lips (pp. 204 ff.) examined the relationship between sub-
clinical vitamin D deficiency and hip fractures in elderly 
patients. Iliac histomorphometry o f the patients with hip 
fracture was divided into three groups: increased turn-
over (increased resorption and formation); impaired 
coupling (increased resorption and normal formation); 
and low turnover (depression of both resorption and 
formation). This analysis was based on static measure-
ments not on kinetic studies with tetracycline labeling. 
In the high turnover group, the plasma calcidiol level 
was low and cortical thickness in the i l ium was signifi-
cantly reduced. None o f the patients had osteomalacia as 
defined elsewhere (Rao, et al, pp. 224 ff.). The data were 
consistent with the view that the early osseous effects of 
vitamin D deficiency are mainly those of secondary 
hyperparathyroidism, leading to accelerated loss of cor-
tical bone. In general, PTH-mediated bone loss probably 
makes little contr ibut ion to postmenopausal osteoporo-
sis (Type I) with vertebral compression fractures, but may 
significantly contribute to senile osteoporosis (Type II) 
leading to hip fractures. 
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